Back to search

Japan· JP-7290708G1025

メタコリン塩化物

A methacholine product containing メタコリン塩化物, registered in Japan by 三和化学研究所, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

On Japan’s NHI price listATC V04CX03

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedメタコリン塩化物ATCV04CX03REGISTER NO.JP-7290708G1025PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Methacholine is registered in 8 of 19 countries.

Countries holding a registration under ATC V04CX03 (methacholine), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 2 of them publish a price we can compare per daily dose

Methacholine · ATC V04CX03

8 / 19 countries

  • Denmark
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
メタコリン塩化物
Manufacturer
三和化学研究所
Country
Japan (JP)
ATC code
V04CX03
ATC class
Methacholine
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

24 interactions on record for methacholine.

Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Methacholine · interactions on record

24 records

  • 18 severe
  • 6 moderate

Most severe, free to view

  • PindololC07AA03severe
  • PropranololC07AA05severe
  • TimololC07AA06severe
  • SotalolC07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methacholine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methacholine products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Germany · Provokit
  • Denmark · Provocholine
  • Spain · Provocholine
  • France · Chlorure De Methacholine Panpharma
  • Ireland · Methacholine Chloride Methapharm
  • Italy · Metacolina Lofarma
  • Netherlands · Provocholine
  • Norway · Provocholine
  • Sweden · Provocholine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cf370de8-5ce1-483b-8d09-a25c35e5fa72
GET /v1/drugs/cf370de8-5ce1-483b-8d09-a25c35e5fa72?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "100mg1瓶",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "7290708G1025",
  "category": "外用薬",
  "price_yen": 7514.9,
  "generic_name": "メタコリン塩化物",
  "product_name_jp": null,
  "therapeutic_class": "7290",
  "transitional_expiry": null
}

See everything about methacholine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.